September 2020

News

September 8, 2020

TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global

TruGenomix recently announced $1.8 million in financing in a seed round led by Sanford Health.…

Super User 0

Love0

News

September 8, 2020

Biotech leaders call for Covid-19 data transparency, FDA independence

WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the…

Super User 0

Love0

Ceres Nanosciences Receives 6 5M NIH Award

News

September 8, 2020

Ceres Nanosciences Receives $6.5M NIH Award

MANASSAS, Va. — September 2, 2020 — Ceres Nanosciences, a privately held company that makes innovative…

Super User 0

Love0

News

September 8, 2020

NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

CHARLOTTESVILLE, Va., Sept. 2, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to…

Super User 0

Love0

News

September 8, 2020

AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine

AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of…

Super User 0

Love0

California developer Alexandria Real Estate proposes office lab building at Baltimore s Port Covington Baltimore Business Journal

News

September 8, 2020

California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal

The 170,000-square-foot building would be located near Rye Street Tavern. (more…)

Super User 0

Love0

News

September 8, 2020

Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS

WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first…

Super User 0

Love0

American Gene Technologies Developing Gene And Cell Therapies

News

September 8, 2020

American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure | BioSpace

HIV therapies, typically cocktails of antiviral drugs, have proven to be very successful in controlling…

Super User 0

Love0

News

September 8, 2020

Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day | BioSpace

GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…

Super User 0

Love0

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large scale distribution of the COVID 19 vaccine candidate Vaccitech

News

September 8, 2020

Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups – Vaccitech

Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and…

Super User 0

Love0

TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global

Biotech leaders call for Covid-19 data transparency, FDA independence

Ceres Nanosciences Receives $6.5M NIH Award

NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine

California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal

Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS

American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure | BioSpace

Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day | BioSpace

Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups – Vaccitech

About BioHealth Innovation

Contact

Connect